1 October 2008

NICE

Attention deficit hyperactivity disorder (ADHD) - Clinical Guideline CG72 (24th September 2008)
The advice in the NICE guideline covers: the care, treatment and support that children, young people and adults with ADHD should be offered; and how families and carers can support people with ADHD. It does not specifically look at: the treatment of children younger than 3 years and the treatment of conditions other than ADHD.
NICE Guideline
Full Guideline

Gull Guideline Appendices
Quick Reference Guide
Understanding NICE Guidance
Costing Template
Costing Report


Autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy - Intervention Procedure Guidance IPG274 (24th September 2008)

Patients with chronic pancreatitis or some pancreatic tumours may require the surgical removal of all, or part, of their pancreas. As the pancreas is responsible for insulin production, surgical removal of the pancreas causes these patients to develop insulin-dependent diabetes. Autologous pancreatic islet cell transplantation involves the removal of parts of the patient's own pancreas (the islet cells, which are responsible for insulin production), after the pancreas has been removed. These cells are then inserted into the patient's liver to restart insulin production within the body.
Guidance
Understanding NICE Guidance
Audit Support

Consultation Comments


Balloon catheter dilation of paranasal sinus ostia for chronic sinusitis - Intervention Procedure Guidance IPG273 (24th September 2008)

Sinusitis occurs when air-filled cavities of the face (the sinuses) become inflamed. Balloon catheter dilation aims to help keep the sinus passages open and unobstructed by gently inflating a small balloon, which is introduced through the nose via a flexible tube.
Guidance
Understanding NICE Guidance
Consultation Comments


Chronic Kidney Disease - Clinical Guideline CG73 (24th September 2008)

The advice in the NICE guideline covers: the tests doctors should use to diagnose long-term kidney problems (chronic kidney disease); the best treatment and care for adults diagnosed with chronic kidney disease, and when they should be referred to specialist renal services; and the general management of chronic kidney disease from a variety of causes including diabetes, high blood pressure and cardiovascular disease. It does not specifically look at the care of: children (aged under 16 years); people receiving kidney dialysis or who have had a kidney transplant; pregnant women with chronic kidney disease; and people with short-lasting damage to their kidneys.
NICE Guideline
Full Guideline
Full Guideline Appendices
Quick Reference Guide
Understanding NICE Guidance
Costing Report
Costing Template


Identifying and supporting people most at risk of dying prematurely - Public Health Intervention Guidance PH15 (24th September 2008)
This guidance aims to identify what works in driving down population mortality rates in disadvantaged areas, where risk of early death is higher than average, with particular reference to proactive case finding and retention and access to services. The recommendations have been developed for smoking cessation services and the provision of statins. Although the referral specified a focus on people in disadvantaged areas, the recommendations are relevant for all those who are disadvantaged, regardless of where they live.
Guidance
Quick Reference Guide (professionals)
Quick Reference Guide (public)
Costing Statement


Influenza (prophylaxis) - amantadine, oseltamivir and zanamivir - Technology Appraisal TA158 (24th September 2008)

NICE has said that its recommendations about oseltamivir and zanamivir should not reduce efforts to give vaccination (also called the flu jab) to people for whom it is recommended in national guidelines. The guidance does not cover widespread epidemics. Oseltamivir and zanamivir are recommended to prevent flu if all of the following apply: The amount of flu virus going around is enough that if someone has a flu-like illness it is likely that it has been caused by the flu virus; The person is in an at-risk group (see page 4); The person has been in contact with someone with a flu-like illness and can start treatment within 36 hours (for zanamivir) or within 48 hours (for oseltamivir); and The person has not been effectively protected by vaccination.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Audit Support
Cost Template


Venous Thromboembolism - dabigatran - Technology Appraisal TA157 (24th September 2008)
Dabigatran etexilate is recommended as a possible treatment to reduce the risk of venous thromboembolism in adults who have surgery to replace their hip or knee joint.
Guidance
Quick Reference Guide
Understanding NICE Guidance
Costing Statement

Audit Support

No comments: